Neogen Corporation Deferred Income Tax Expense (Benefit)
Neogen Corporation (NEOG) reported Deferred Income Tax Expense (Benefit) of -$24.30 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-30
- Neogen Corporation deferred income tax expense (benefit) for the quarter ending 2026-05-31 was -$8.80M.
- Neogen Corporation deferred income tax expense (benefit) for the quarter ending 2026-02-28 was -$4.27M.
- Neogen Corporation deferred income tax expense (benefit) for the quarter ending 2025-11-30 was -$5.40M.
- Neogen Corporation deferred income tax expense (benefit) for the quarter ending 2025-08-31 was -$5.83M.
- Neogen Corporation deferred income tax expense (benefit) for fiscal 2026 was -$24.30M.
- Neogen Corporation deferred income tax expense (benefit) for fiscal 2025 was -$57.80M.
- Neogen Corporation deferred income tax expense (benefit) for fiscal 2024 was -$27.40M.
- Neogen Corporation deferred income tax expense (benefit) for fiscal 2023 was -$19.23M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$13.07M derived: sum of 2 quarters · filed 2026-07-30 | -$18.47M derived: sum of 3 quarters · filed 2026-07-30 | -$24.30M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | -$4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$9.67M derived: sum of 2 quarters · filed 2026-04-09 | -$15.50M 10-Q · filed 2026-04-09 | -$40.20M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | -$5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$11.23M 10-Q · filed 2026-01-08 | -$35.93M derived: sum of 3 quarters · filed 2026-07-30 | -$45.11M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | -$5.83M 10-Q · filed 2025-10-09 | -$30.53M derived: sum of 2 quarters · filed 2026-07-30 | -$39.71M derived: sum of 3 quarters · filed 2026-07-30 | -$54.51M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | -$24.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$33.88M derived: sum of 2 quarters · filed 2026-07-30 | -$48.68M derived: sum of 3 quarters · filed 2026-07-30 | -$57.80M 10-K · filed 2026-07-30 | -$57.78M 10-K · filed 2025-07-30 | |
| 2025-02-28 | -$9.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$23.98M derived: sum of 2 quarters · filed 2026-04-09 | -$33.10M 10-Q · filed 2026-04-09 | -$33.11M 10-Q · filed 2025-04-09 | -$60.60M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | -$14.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$23.92M 10-Q · filed 2026-01-08 | -$51.42M derived: sum of 3 quarters · filed 2026-07-30 | -$52.50M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | -$9.12M 10-Q · filed 2025-10-09 | -$36.62M derived: sum of 2 quarters · filed 2026-07-30 | -$37.70M derived: sum of 3 quarters · filed 2026-07-30 | -$37.52M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | -$27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$28.58M derived: sum of 2 quarters · filed 2026-07-30 | -$28.40M derived: sum of 3 quarters · filed 2026-07-30 | -$27.40M 10-K · filed 2026-07-30 | -$27.42M 10-K · filed 2024-07-30 | |
| 2024-02-29 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | -$900.00K derived: sum of 2 quarters · filed 2025-04-09 | $98.00K 10-Q · filed 2025-04-09 | -$13.83M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $1.18M 10-Q · filed 2025-01-15 | -$12.75M derived: sum of 3 quarters · filed 2025-07-30 | -$16.07M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | $998.00K 10-Q · filed 2024-10-10 | -$12.93M derived: sum of 2 quarters · filed 2025-07-30 | -$16.25M derived: sum of 3 quarters · filed 2025-07-30 | -$16.79M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | -$13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | -$17.25M derived: sum of 2 quarters · filed 2025-07-30 | -$17.79M derived: sum of 3 quarters · filed 2025-07-30 | -$19.23M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | -$3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$3.86M derived: sum of 2 quarters · filed 2024-04-09 | -$5.30M 10-Q · filed 2024-04-09 | -$9.27M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$1.98M 10-Q · filed 2024-01-09 | -$5.96M derived: sum of 3 quarters · filed 2024-07-30 | -$6.59M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | -$1.44M 10-Q · filed 2023-10-10 | -$5.41M derived: sum of 2 quarters · filed 2024-07-30 | -$6.05M derived: sum of 3 quarters · filed 2024-07-30 | -$6.12M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$4.61M derived: sum of 2 quarters · filed 2024-07-30 | -$4.68M derived: sum of 3 quarters · filed 2024-07-30 | -$4.70M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | -$632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | -$705.00K derived: sum of 2 quarters · filed 2023-04-04 | -$720.00K 10-Q · filed 2023-04-04 | |||
| 2021-11-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$88.00K 10-Q · filed 2023-01-09 | ||||
| 2021-08-31 | -$15.00K 10-Q · filed 2022-09-30 | |||||
| 2021-05-31 | -$640.00K 10-K · filed 2023-08-15 | |||||
| 2020-05-31 | $1.60M 10-K · filed 2022-07-27 | |||||
| 2019-05-31 | $1.20M 10-K · filed 2021-07-30 | |||||
| 2018-05-31 | -$3.00M 10-K · filed 2020-07-30 | |||||
| 2017-05-31 | -$292.00K 10-K · filed 2019-07-30 | |||||
| 2016-05-31 | $1.91M 10-K · filed 2018-07-27 | |||||
| 2015-05-31 | $496.00K 10-K · filed 2017-07-28 | |||||
| 2014-05-31 | -$542.00K 10-K · filed 2016-07-29 | |||||
| 2013-05-31 | $287.00K 10-K · filed 2015-07-30 | |||||
| 2012-05-31 | $1.34M 10-K · filed 2014-07-30 | |||||
| 2011-05-31 | $2.25M 10-K · filed 2013-07-30 | |||||
| 2010-05-31 | -$200.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |